These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3156616)

  • 1. In vivo detection and partial characterization of effector and suppressor cell populations in spleens of mice with large metastatic fibrosarcomas.
    Dent LA; Finlay-Jones JJ
    Br J Cancer; 1985 Apr; 51(4):533-41. PubMed ID: 3156616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the phenotypes of cells mediating anti-tumour immunity at various stages of tumour progression in mice.
    Dent LA; Spencer LK; Attridge S; Finlay-Jones JJ
    Immunol Cell Biol; 1989 Dec; 67 ( Pt 6)():403-12. PubMed ID: 2696727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
    Lynch DH; Gurish MF; Daynes RA
    Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressor T cells in BCG-treated mice interfere with an in vivo specific antitumoral immune response.
    Payelle B; Brulay-Rosset M; Poupon MF; Lespinats G
    Br J Cancer; 1984 Jun; 49(6):759-68. PubMed ID: 6234012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo splenic irradiation eradicates suppressor T-cells causing the regression and inhibition of established tumor.
    Enker WE; Jacobitz JL
    Int J Cancer; 1980 Jun; 25(6):819-25. PubMed ID: 14768713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of selected splenic irradiation on growth of meth A-fibrosarcoma in mice and partial characterization of splenic effector and suppressor cell populations.
    Sasaki A; Fuchimoto S; Orita K
    Acta Med Okayama; 1990 Dec; 44(6):309-14. PubMed ID: 2150147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages.
    Elgert KD; Farrar WL
    J Immunol; 1978 Apr; 120(4):1345-53. PubMed ID: 305939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of tolerance to a murine fibrosarcoma in two zones of dosage--the involvement of suppressor cells.
    McBride WH; Howie SE
    Br J Cancer; 1986 Jun; 53(6):707-11. PubMed ID: 2941045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of T suppressor cells in the cycling of the immune response against a murine fibrosarcoma.
    Payelle B; Lespinats G; Tlouzeau S
    Int J Cancer; 1984 Jul; 34(1):95-100. PubMed ID: 6235194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to chemically induced tumours: correlation of responding cell class with in vivo inhibition of tumour growth.
    Calderwood MB; Forbes JT; Smith RT
    Br J Cancer; 1981 Apr; 43(4):505-16. PubMed ID: 6972224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations into the nature of Igh-V region-restricted T cell interactions by using antibodies to antigens on methylcholanthrene-induced sarcomas. I. Analysis of an Igh-V-restricted suppressor-inducer factor.
    Flood PM
    J Immunol; 1985 Mar; 134(3):1665-72. PubMed ID: 2578515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro induction of tumour-specific immunity V. Detection of common antigenic determinatnts of murine fibrosarcomas.
    Burton RC; Warner NL
    Br J Cancer; 1978 Feb; 37(2):159-70. PubMed ID: 75739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceleration of allogeneic antitumor immunity with immune RNA in vitro and T-cell suppression by L1210 tumor bearer spleen cells.
    Miura T; Maekawa T; Kurashige S; Mitsuhashi S
    Cancer Res; 1981 Feb; 41(2):383-98. PubMed ID: 6160907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo regulation of the cytolytic T cell response to hapten-altered self: suppressor T cells induced in the regional lymph nodes by exposure to syngeneic spleen cells.
    Wong HL; Battisto JR
    Eur J Immunol; 1984 Jul; 14(7):629-33. PubMed ID: 6235115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophages and lymphoid tissues in mice with concomitant tumour immunity.
    Nelson DS; Kearney R
    Br J Cancer; 1976 Sep; 34(3):221-6. PubMed ID: 973997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological analysis of enhanced spontaneous metastasis in WKA rats following cryosurgery.
    Shibata T; Suzuki K; Yamashita T; Takeichi N; Mark M; Hosokawa M; Kobayashi H; Arisue M
    Anticancer Res; 1998; 18(4A):2483-6. PubMed ID: 9703896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenic immune effector and suppressor cells in mice bearing a growing plasmacytoma.
    Chen YH; Anderson AB; Williams KG
    Cancer Res; 1985 Nov; 45(11 Pt 1):5473-9. PubMed ID: 2932218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of suppressor cells by a tumor-derived suppressor factor.
    Jessup JM; Le Grue SJ; Kahan BD; Pellis NR
    Cell Immunol; 1985 Jun; 93(1):9-25. PubMed ID: 3158410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.
    Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y
    Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of soluble "blocking" and "suppressor" factors from normal lymphocytes treated with RNA from spleens of tumour-bearing mice.
    Pennline KJ; Evans SB; Nawrocki JF; Rees JC; Johnson CS; Vallera DA; Dodd MC
    Br J Cancer; 1979 Mar; 39(3):247-58. PubMed ID: 313804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.